NOTMAN DONALD (Chief Financial Officer) sold 3.0% of their position (11.45K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $103.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/17/2026ACC: 0001104659-26-016668
Officer· Chief Financial Officer
Since Aug 2018
-11.45K
Net shares
Net seller
$103.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.45K
Price / share
$9.04
Trade value
$103.47K
% of position
3.0%
2/12/2026
377.80K→366.36K
Total
Net shares
−11.45K
Net value
-$103.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | S · Sale | −11.45K | $9.04 | $103.47K | 3.0% | 377.80K | 366.36K |
| Total | −11.45K | -$103.47K | ||||||
Derivative Transactions0
No derivative transactions reported